+499.5%
MRNA vs SMTC
+154.8%
+344.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SMTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +9.2% | -11.5% | -0.8% |
| 7D | +5.5% | +12.7% | -7.3% | +7.6% |
| 30D | +158.7% | +22.0% | +136.8% | +162.3% |
| 3M | +182.1% | -12.7% | +194.8% | +190.1% |
| 6M | +151.8% | +64.8% | +87.0% | +129.6% |
| YTD | +393.6% | +100.7% | +292.9% | +329.7% |
| 1Y | +499.5% | +146.9% | +352.6% | +410.6% |
| All | +499.5% | +154.8% | +344.7% | +410.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SMTC.
Daily Out/Under-Performance
Portfolio return minus SMTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SMTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SMTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling